(MedPage Today) — NEW ORLEANS — People with diabetes may be among those who still benefit from primary prevention aspirin, a large observational study suggested.
In contrast with the unimpressive track record of aspirin in most people, there…
Source link : https://www.medpagetoday.com/meetingcoverage/aha/118417
Author :
Publish date : 2025-11-10 17:12:00
Copyright for syndicated content belongs to the linked Source.
